The Union Health Ministry on Monday dropped the use of Ivermectin, Doxycycline and Hydroxychloroquine from its COVID-19 treatment guidelines.
The revised guidelines have also dropped zinc and multivitamins that were earlier prescribed by doctors to treat asymptomatic or mildly symptomatic COVID-19 patients.
The government has retained only antipyretic drugs for fever and antitussive for cold symptoms.
The advisory from the Directorate General of Health Services (DGHS) comes as India continues to witness a significant fall in COVID-19 cases.
The new guidelines stressed on the importance of abiding by COVID-19 appropriate behavior such as mask, strict hand hygiene, and physical distancing. The ministry further advised people who experience COVID symptoms to seek teleconsultations and to consume a healthy balanced diet with proper hydration.
It has also discouraged diagnostic tests or investigations for asymptomatic and mild patients.
The guidelines also suggested that people may take antipyretic and anti-tussive for symptomatic relief, and inhalation of budesonide (given via metered-dose inhaler with space device) at a dose of 800 mcg twice a day for 5 days for a cough.
The guidelines said that Remedesivir should be used only in select moderate/severe hospitalised COVID-19 patients on supplemental oxygen within 10 days of onset of disease.
India reported 1,00,636 fresh COVID-19 cases, the lowest in 61 days, taking the infection tally to 2,89,09,975, while the number of active cases dropped to 14,01,609, according to the Union Health Ministry’s data updated on Monday.
(Edited by: By Aditi Gautam)
First Published: IST